Early Phase 1 Chronic Rhinosinusitis Trial, Not Yet Recruiting NCT07635459 Sponsor: The First Affiliated Hospital of Xinxiang Medical College Condition: Chronic Rhinosinusitis
Back to Chronic Rhinosinusitis

Early Phase 1 Chronic Rhinosinusitis Trial, Not Yet Recruiting

NCT07635459
Not Yet Recruiting Early Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 65 years old (any gender)
  • You have been diagnosed with chronic rhinosinusitis (long-term sinus inflammation) according to recognised medical guidelines
  • Your sinus condition has lasted for more than 12 weeks
  • Your nasal symptoms have been measured by a doctor using a scope and scored at a certain level of severity (confirm with trial site)
  • Your symptom questionnaire score meets a minimum threshold of severity (confirm with trial site)
  • Your nasal symptoms have been stable over the past month, or any recent flare-ups did not need antibiotic or steroid tablets/injections
  • You are willing and able to give written consent to take part

Who may not be able to join:

  • You have had sinus surgery in the last 6 months, or you have a structural nasal problem that would need surgery
  • You have a specific type of sinus condition caused by fungus, a dental problem, or nasal polyps (growths inside the nose)
  • You have a condition affecting how the tiny hairs in your airways work, cystic fibrosis, or a seriously weakened immune system
  • You have taken steroid tablets, immune-suppressing medicines, or antibiotics in the last 4 weeks
  • You have used steroid nasal sprays, antihistamines, or certain allergy medicines in the last 2 weeks
  • You have a known allergy to any of the specific ingredients used in this trial (confirm with trial site)
  • You are pregnant, breastfeeding, or planning to become pregnant
  • You have a serious ongoing health condition such as uncontrolled diabetes, high blood pressure, or an autoimmune disease
  • You have had any form of cancer in the past 5 years
  • You are currently taking part in another clinical trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

Contact this trial

Phone: 86+13837310327

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Early Phase 1
Sponsor
The First Affiliated Hospital of Xinxiang Medical College
Registry
ClinicalTrials.gov
Start date
1 July 2026
Est. completion
30 June 2027

Primary endpoints

Number of Participants with Treatment-Related Adverse Events

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov